Alivus Life Sciences Limited
A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.
Family office and investment vehicle of Mukul Agrawal, founded in 1993. Mukul's disclosed listed equity book stood at ~Rs 6,604 cr across 73 stocks as of Q3 FY26, with healthcare and pharma the largest sector concentration: Neuland Labs, Zota Health Care, Onesource Specialty Pharma, Dishman Carbogen Amcis, Strides Pharma. Param Capital is the entity behind his bulk-deal activity in small and midcaps.
